BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Anavex Life Sciences Corp. 

50 Harrison St.
Suite 315A
Hoboken  New Jersey  07030  U.S.A.
Phone: 416-489-0092 or 866-505-2895 Fax: n/a


SEARCH JOBS










 Company News
Anavex Life Sciences Corp. (AVXL.OB) To Present At Biotech Showcase 2015 In San Francisco 12/18/2014 8:01:10 AM
Anavex Life Sciences Corp. (AVXL.OB) Begins Enrollment Of Alzheimer's Patients In Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS 12/16/2014 7:45:42 AM
Anavex Life Sciences Corp. (AVXL.OB) Upgrades To OTCQX Marketplace 12/12/2014 7:31:22 AM
Anavex Life Sciences Corp. (AVXL.OB) Announces Positive Phase 1 Data For ANAVEX 2-73, Lead Candidate For The Treatment Of Alzheimer's 11/17/2014 10:37:14 AM
Anavex Life Sciences Corp. (AVXL.OB) To Present Full Phase 1 Clinical Trial Data For ANAVEX 2-73 At CNS Summit 2014 Conference 11/10/2014 7:31:21 AM
Neuronetrix, Inc. Has Been Selected By Anavex Life Sciences Corp. (AVXL.OB) To Support The Upcoming Phase 2a Clinical Trial For ANAVEX 2-73 11/7/2014 8:27:43 AM
Anavex Life Sciences Corp. (AVXL.OB) To Present At SeeThruEquity Investor Conference In New York City 11/6/2014 1:06:01 PM
Anavex Life Sciences Corp. (AVXL.OB) Receives Regulatory Approval To Initiate Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS For Alzheimer's Disease 11/3/2014 7:27:13 AM
Institutional Investor Lincoln Park Capital Increases Ownership In Anavex Life Sciences Corp. (AVXL.OB), Pays Over 25% Premium To Market 10/27/2014 7:56:51 AM
Anavex Life Sciences Corp. (AVXL.OB) Supports Alzheimer's Foundation Of America's 3rd Annual Concepts In Care Educational Conference 9/8/2014 7:57:17 AM
12345678910...